Clinical Trials Browser

Phase 2 × Vomiting × Megestrol Acetate × Clear all

NCT04430361 2020-06-12

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Phase 2 Unknown

Neoplasms, Vomiting